If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
ST. PETERSBURG, Fla., July 24 (HSMN NewsFeed) — Smith & Nephew Inc.’s Advanced Wound Management division (LSE: SN ; NYSE: SNN ) announced that the United States Patent and Trademark Office (Patent Office) has issued actions in re-examination proceedings…
Devices, Wound Care, Litigation
Smith & Nephew, Kinetic Concepts, negative pressure wound therapy
Posts from ‘July, 2009’
United States Patent Office Issues Decision in Re-examination Proceedings
SAPHRIS(R) (asenapine) Meets Primary Endpoint in Long-Term Extension Study in Patients With Predominant, Persistent Negative Symptoms of Schizophrenia
KENILWORTH, N.J., July 24 (HSMN NewsFeed) — Schering-Plough Corporation (NYSE: SGP ) today announced that its investigational agent SAPHRIS(R) (asenapine) met the primary endpoint over one year of treatment in an extension study in patients with predomi…
Biopharmaceuticals
Schering-Plough, SAPHRIS, asenapine, schizophrenia
FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics’ Focus Diagnostics Business
MADISON, N.J., July 24 (HSMN NewsFeed) — Quest Diagnostics Incorporated (NYSE: DGX ), the world’s major provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has granted an emergency…
Diagnostics, FDA
Quest Diagnostics, Focus Diagnostics, H1N1, influenza
Cardiorobotics Closes $11.6M Series A Financing to Advance Clinical Development of Snake Robot for Surgery
PITTSBURGH, July 24 (HSMN NewsFeed) — Cardiorobotics, Inc., a medical device company developing snake robot technologies for use in a wide range of surgical and interventional applications has closed on an $11.6 Million private equity Series A round of …
Devices, Cardiology, Surgery, Venture Capital
Cardiorobotics, cardioARM
NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test
FT. MYERS, Fla., July 24 (HSMN NewsFeed) — NeoGenomics, Inc. (OTC Bulletin Board: NGNM ), a top provider of cancer genetics testing services announced today that it has entered into a Strategic Supply Agreement with Abbott (NYSE: ABT ). The Agreemen…
Diagnostics, Oncology
NeoGenomics, Abbott, fluorescence in situ hybridization, melanoma
Neusoft Medical’s Latest Innovation, NeuViz 16 CT Scanner, Approved by FDA for the U.S. Market
SHENYANG, China, July 24 –(HSMN NewsFeed)– Neusoft Medical Systems Co., Ltd. (Neusoft Pharma), a wholly owned subsidiary of Neusoft Corporation (600718.SH), officially announced that its newly developed Computed Tomography(CT) system, NeuViz 16 multi-sl…
Devices, Radiology, FDA
Neusoft, NeuViz 16, multi-slice, CT scanner
Regeneron Receives European Medicines Agency Positive Opinion for Marketing Authorization of Rilonacept for the Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
European marketing approval for this rare orphan condition anticipated in late 2009 TARRYTOWN, N.Y.–(HSMN NewsFeed)–Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN ) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the Eu…
Biopharmaceuticals, Regulatory
Regeneron Pharmaceuticals, rilonacept, Cryopyrin-Associated Periodic Syndromes
Schering-Plough Reports Proposed Settlement in Litigation Involving Planned Merger with Merck
KENILWORTH, N.J., July 24 (HSMN NewsFeed) — Schering-Plough Corporation (NYSE: SGP ) today reported a proposed settlement, subject to Court approval, to resolve litigation seeking to enjoin the planned merger with Merck & Co., Inc., and other forms of r…
Biopharmaceuticals, Litigation
Schering-Plough, Merck
Calypso Pathology and Varian Clinical Systems Enter into Master Development Agreement for Radiation Therapy Cancer Treatment
Combined Technology Solution Enables Control over Radiation Beam for More Accurate Delivery and Fewer Side Effects from Radiation SEATTLE–(HSMN NewsFeed)–Calypso(R) Clinical Technologies, Inc., a developer of real-time localization technology used for …
Devices, Oncology
Calypso Clinical, Varian Clinical Systems, radiotherapy, RapidArc, IMRT
Elekta CMS Software Receives FDA 510(k) Clearance for Monaco VMAT Treatment Planning Solution
ANAHEIM, Calif., July 24 (HSMN NewsFeed) — Elekta CMS Software has received FDA 510(k) clearance for the VMAT enhancement to Monaco(R), an advanced IMRT treatment planning solution that combines new levels of scientific insight with precise dose control…
Devices, Oncology, FDA
Elekta, Monaco, VMAT, IMRT, radiotherapy
